Results for:(36 found)
Dec 7, 2012 12:31PM on Top StocksBy MSN Money Partner

Roche is upgraded to 'overweight,' while Novartis is downgraded to 'equal weight.'

Nov 15, 2012 12:55PM on Top StocksBy InvestorPlace

Next-gen drugs can help power growth and income alike.

Oct 31, 2012 10:38AM on Top StocksBy InvestorPlace

The revenue in question seems too small to make a difference.

Oct 26, 2012 2:33PM on Top StocksBy Minyanville.com

The stock falls after investors get a peek at the royalty-rate structure that pharma giant Roche will pay if a promising new cancer drug is approved.

Oct 23, 2012 11:56AM on Top StocksBy Stock Traders Daily

The pharma's earnings may not look great, but bailing out could prove costly for investors if its Alzheimer's drug is successful.

Oct 18, 2012 11:30AM on Top StocksBy Minyanville.com

Shares dip on news that the FDA needs more review time.

Tags: BIIBNVS
Aug 15, 2012 12:45PM on Top StocksBy TheStockAdvisors

With antibodies produced from mouse and human components, this biotech is advancing drug research.

Jun 20, 2012 3:31PM on Top StocksBy Minyanville

Investors hope the company has a next-generation treatment for the virus. The new data will fuel more takeover talk.

VIDEO ON MSN MONEY

DATA PROVIDERS

Copyright © 2014 Microsoft. All rights reserved.

Fundamental company data and historical chart data provided by Morningstar Inc. Real-time index quotes and delayed quotes supplied by Morningstar Inc. Quotes delayed by up to 15 minutes, except where indicated otherwise. Fund summary, fund performance and dividend data provided by Morningstar Inc. Analyst recommendations provided by Zacks Investment Research. StockScouter data provided by Verus Analytics. IPO data provided by Hoover's Inc. Index membership data provided by Morningstar Inc.

TOP STOCKS

How to invest when the world is in chaos

As geopolitical tensions threaten to spin out of control, investors are wondering how best to position their portfolios for the global turmoil.

More

MARKET DISPATCHES

No more Dispatches; here's where to find market news

The Market Dispatches column has been discontinued. Here's where to find the latest stock and business news on MSN Money, and the latest from market writer Charley Blaine.

More